CORE--TUMOR BIOLOGY
CORE--TUMOR BIOLOGY
批准号:
6300536
负责人:
LI MAO
金额:
$25.29万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-14 至 2002-01-10
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The main goal of this program project is to develop new nucleic acid
hybridization technologies, advanced detection methods based on charge
couped devices, and automated sample preparation and handling that could
be used in an automated workstation to analyze the expression of large
numbers of mRNA species, loss of heterozygosity, and specific gene
mutations simultaneously, in a single sample of lung tissue. It is
crucial to document and quantify the performance of these devices on
real clinical specimens. Additionally, the results obtained from these
newly developed devices must be comparable to those obtained from
conventional methods. Tumor Biology Core (TBC) is responsible for
coordinating sample collection, providing precharacterized model tumor
panels and uncharacterized tumor panels for the standardization of
devices developed in Project 1 and Project 3. The TBC will also
identify newly identified genetic alterations n lung cancers as a source
of addition potential valuable markers for the Program Project. 1) To
establish a tissue bank and keep track of all tissue materials related
to the Program Project. 2) To prepare tissue samples for conventional
and multi parameter genetic analysis. 3) To analyze genetic alterations
in lung cancers using conventional means to provide standards for multi
parameter analysis or validate results from the multi parameter
analysis. 4) To identify additional genetic alterations and/or changes
in mRNA expression which are potentially important in lung tumorigenesis
for up-dating probe panels used in the program project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Early detection of breast cancer serum antigens with lambodies
-
批准号:8619768
-
项目类别:
-
资助金额:$16.69万
-
财政年份:2013
-
负责人:LI MAO
-
依托单位:
Early detection of breast cancer serum antigens with lambodies
-
批准号:8800538
-
项目类别:
-
资助金额:$16.69万
-
财政年份:2013
-
负责人:LI MAO
-
依托单位:
ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS
-
批准号:8065913
-
项目类别:
-
资助金额:$30.19万
-
财政年份:2009
-
负责人:LI MAO
-
依托单位:
ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS
-
批准号:8471004
-
项目类别:
-
资助金额:$12.1万
-
财政年份:2009
-
负责人:LI MAO
-
依托单位:
ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS
-
批准号:7653375
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2009
-
负责人:LI MAO
-
依托单位:
ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS
-
批准号:8731801
-
项目类别:
-
资助金额:$15.79万
-
财政年份:2009
-
负责人:LI MAO
-
依托单位:
ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS
-
批准号:8261869
-
项目类别:
-
资助金额:$30.19万
-
财政年份:2009
-
负责人:LI MAO
-
依托单位:
HDGF: a novel biomarker and therapetic target of lung cancer
-
批准号:7879366
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2008
-
负责人:LI MAO
-
依托单位:
HDGF: a novel biomarker and therapetic target of lung cancer
-
批准号:8071565
-
项目类别:
-
资助金额:$30.19万
-
财政年份:2008
-
负责人:LI MAO
-
依托单位:
HDGF: a novel biomarker and therapetic target of lung cancer
-
批准号:8250458
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2008
-
负责人:LI MAO
-
依托单位:
HDGF: a novel biomarker and therapetic target of lung cancer
-
批准号:7515153
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2008
-
负责人:LI MAO
-
依托单位:
HDGF: a novel biomarker and therapetic target of lung cancer
-
批准号:7657404
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2008
-
负责人:LI MAO
-
依托单位:
MOLECULAR DEFECTS IN ORAL CARCINOGENESIS
-
批准号:6990028
-
项目类别:
-
资助金额:$20.79万
-
财政年份:2004
-
负责人:LI MAO
-
依托单位:
CORE--TUMOR BIOLOGY
-
批准号:6613348
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2002
-
负责人:LI MAO
-
依托单位:
CORE--TUMOR BIOLOGY
-
批准号:6499807
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2000
-
负责人:LI MAO
-
依托单位:
CORE--TUMOR BIOLOGY
-
批准号:6103351
-
项目类别:
-
资助金额:$25.29万
-
财政年份:1999
-
负责人:LI MAO
-
依托单位:
CORE--TUMOR BIOLOGY
-
批准号:6269827
-
项目类别:
-
资助金额:$25.87万
-
财政年份:1998
-
负责人:LI MAO
-
依托单位:
MOLECULAR DEFECTS IN ORAL CARCINOGENESIS
-
批准号:7681255
-
项目类别:
-
资助金额:$13.12万
-
财政年份:--
-
负责人:LI MAO
-
依托单位:
Experimental Therapeutics (ET)
-
批准号:9326174
-
项目类别:
-
资助金额:$4.86万
-
财政年份:--
-
负责人:LI MAO
-
依托单位:
MOLECULAR DEFECTS IN ORAL CARCINOGENESIS
-
批准号:7286782
-
项目类别:
-
资助金额:$21.99万
-
财政年份:--
-
负责人:LI MAO
-
依托单位:
海外基金